Mikkel Holm Vendelbo

VIP, Associate Professor

Aarhus University
Country flagDenmark

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Herpes simplex encephalitis (HSE) is a devastating disease with high mortality and serious sequelae. Genetic defects in the IFN-I pathway predispose individuals to HSE, but underlying mechanisms remain unclear. Using transgenic mice with the IRF3 R278Q mutation, ortholog to HSE-associated IRF3 R285Q, and iPSC-derived CNS cells from a pediatric patient carrying the variant, we investigated mechanisms in HSE. IRF3 R278Q transgenic mice exhibited aggravated HSV-1 brain disease and elevated CNS viral loads. Accordingly, microglia from the IRF3 R278Q mice showed reduced HSV-1–induced IFN-I expression. Surprisingly, unaltered Ifnb levels along with elevated levels of inflammatory cytokines were detected in infected transgenic mouse brains, correlating with higher viral load. This was successfully modeled in patient microglia. Multiomics-based immune profiling revealed an inflammatory monocyte population in the infected IRF3 R278Q mouse brain, which was enriched for NF-κB activation. NF-κB inhibition improved disease outcomes, surpassing the effect of acyclovir. These findings suggest that IFN-I defects lead to elevated levels of HSV-1 replication in the brain, which subsequently enables NF-κB–driven immunopathology, offering insights with therapeutic potential.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Objectives Vascular graft or endograft infections (VGEIs) pose a detrimental complication when using vascular grafts and are challenging to diagnose and treat. This study examined the progression of infection and the antimicrobial response in VGEI using [18F]Fluorodeoxyglucose (chemical name, 2-Deoxy-2-[18F]fluoroglucose) (FDG) positron emission tomography (PET), ex vivo bacterial quantification, and histology in a VGEI rat model. Methods In this experimental study, 97 male Sprague–Dawley rats had a polytetrafluorethylene graft surgically implanted in the carotid artery. The graft was either preinoculated with Staphylococcus aureus, S. epidermidis, or saline. Up to 31 days after surgery, rats were FDG-PET-scanned. Subsequently, they were killed, and the implants were retrieved for analysis. A subgroup of infected rats received daptomycin and rifampicin from days 20 to 29. Results Tracer uptake around the implant, measured by maximum standardized uptake value (SUVmax), declined over time in all groups. Between groups, SUVmax was highest in untreated S. aureus-infected rats. When comparing antibiotic-treated and uninfected rats by day 31, there was no difference in SUVmax, although the treated rats were still infected. Histology revealed widespread inflammation by day 10 in S. aureus-infected rats, which decreased by days 20 and 31 with encapsulation of the infection, alongside increased plasma interleukin-10. Conclusions FDG-PET differentiated untreated S. aureus-infected rats from uninfected ones but failed to monitor infection progression, as SUVmax declined over time despite a constant bacterial load. FDG-PET could not distinguish between uninfected rats and those with suppressed infection, likely due to reduced inflammation and encapsulation of the infection.

Year:

2026

Year:

2026

Year:

2026

Background and purpose: Quantification/mapping of tumor hypoxia may guide pretreatment decision-making in radiation oncology. Hypoxia-selective positron emission tomography (PET) tracers, like 18F-fluoroazomycin arabinoside (FAZA), allow assessment of hypoxia, but since hypoxia stimulates glycolysis, fluorodeoxyglucose (FDG) and hypoxia-PET may provide overlapping/similar information. Clinical dual-tracer PET studies are highly complex and remain inconclusive. Accordingly, we developed dual-tracer autoradiography techniques to allow high-resolution assessment of the spatial coupling of FAZA and 14C-2DG (FDG-analogue), without the time-separation and co-registration-related inaccuracies intrinsic to PET. Patient/material and methods: Orthotopic lung adenocarcinomas were induced in CRISPR/Cas9 knock-in mice. Mammary adenocarcinomas developed spontaneously in transgenic mice overexpressing ErbB2 (Her2). Patient-derived-xenografts (PDX) were established in immunocompromised mice using biopsies from oropharyngeal cancer patients. Tumor growth was followed by MRI/Caliper measurements. Mice were administered with FAZA (~40 MBq)/14C-2DG (37 kBq)/pimonidazole and sacrificed. Tumor cryosections were analyzed for FAZA/14C-2DG using dual-tracer autoradiography followed by histological stainings. Complementary autoradiograms were co-registered and covered by a square-grid (0.5 × 0.5 mm), and Pearson correlation coefficients (R) were calculated. Results/Interpretation: Hypoxic sub-volumes (FAZA/pimonidazole) were commonly present. A reasonable spatial overlap between FAZA and 14C-2DG was observed in most lung and oropharyngeal tumors with R typically exceeding 0.55. In the breast tumor model, the extent of overlap between FAZA and 14C-2DG varied widely with R ranging from 0.03 to 0.82, which may relate to intertumor mutational differences in this Her2+ oncogene-driven model. Our results suggest a putative role for FDG-PET to identify hypoxic foci and guide dose-escalation.

Year:

2025

Background The axolotl is a prominent model organism of heart regeneration due to its ability to anatomically and functionally repair the heart after an injury that mimics human myocardial infarction. In humans, such an injury leads to permanent scarring. Cardiac regeneration has been linked to metabolism and the oxygenation state, but so far, these factors remain to be detailed in the axolotl model. In this descriptive study, we have investigated metabolic changes that occurred during cardiac regeneration in the axolotl. Results We describe systemic and local cardiac metabolic changes after injury involving an early upregulation of glucose uptake and nucleotide biosynthesis followed by a later increase in acetate uptake. We detect several promising factors and metabolites for future studies and show that, unlike other popular animal models capable of intrinsic regeneration, the axolotl maintains its cardiac regenerative ability under hyperoxic conditions. Conclusions Axolotls undergo dynamic metabolic changes during the process of heart regeneration and display a robust reparative response to cardiac cryo‐injury, which is unaffected by hyperoxia.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (59)

Stefanie Fruhwürth

Group leader

University of Gothenburg

SWEDEN
View details

Karin Dedek

Adjunct Professor

Carl von Ossietzky Universität Oldenburg

GERMANY
View details

Niels Peter Revsbech

Professor

Aarhus University

DENMARK
View details

Niels Jessen

Head of Research

Aarhus University

DENMARK
View details

Johanne Ahrenfeldt

Aarhus University

DENMARK
View details

Coen P. H. Elemans

Professor

University of Southern Denmark

DENMARK
View details

Signe Borgquist

VIP, Clinical Professor and Chair

Aarhus University

DENMARK
View details

Jacob Kinggaard Lilja-Fischer

DVIP-part-time lecturer, Part-time Lecturer

Aarhus University

DENMARK
View details

Michael Horsman

Professor

Aarhus University

DENMARK
View details

Anne Kruse Hollensen

Aarhus University

DENMARK
View details

Trine Ørhøj Barkholt

Aarhus University

DENMARK
View details

Laura Teodori

ETH Zürich

SWITZERLAND
View details

Hans Zischka

Technical University of Munich

GERMANY
View details

Kirstine Lykke Nielsen

VIP, Associate Professor

Aarhus University

DENMARK
View details

Niels Bassler

VIP, Professor

Aarhus University

DENMARK
View details

Christian Staehr

DVIP-part-time lecturer, Part-time Lecturer

Aarhus University

DENMARK
View details

Jianhai Du

West Virginia University

UNITED STATES
View details

Ole Lajord Munk

Professor of Medical Physics

Aarhus University

DENMARK
View details

Mads Kjolby

Aarhus University Hospital

DENMARK
View details

Thomas Baad-Hansen

VIP, Clinical Professor

Aarhus University

DENMARK
View details

Johan Palmfeldt

VIP, Associate Professor

Aarhus University

DENMARK
View details

Line Reinert

VIP, Associate Professor

Aarhus University

DENMARK
View details

Asger Andersen

VIP, Associate Professor

Aarhus University

DENMARK
View details

Rasmus Bak

VIP, Associate Professor

Aarhus University

DENMARK
View details

Christian Damsgaard

VIP, Associate Professor

Aarhus University

DENMARK
View details

Jeremy Semrau

University of Michigan

UNITED STATES
View details

Hans‐Christian Beck

Senior Researcher

Odense University Hospital

DENMARK
View details

Lars Christian Gormsen

VIP, Clinical Professor and Chair

Aarhus University

DENMARK
View details

André H. Dias

VIP, Clinical Associate Professor

Aarhus University

DENMARK
View details

Jesper Skovhus Thomsen

VIP, Professor

Aarhus University

DENMARK
View details

Thomas Damgaard Sandahl

VIP, Clinical Professor

Aarhus University

DENMARK
View details

Frederik Teicher Kirk

Aarhus University

DENMARK
View details

Per Bendix Jeppesen

Associate Prof, PhD

Aarhus University

DENMARK
View details

Joanna Kalucka

Assistant Professor

Aarhus University

DENMARK
View details

Aage Kristian Olsen Alstrup

VIP, Associate Professor

Aarhus University

DENMARK
View details

Søren Baarsgaard Hansen

VIP, Associate Professor

Aarhus University

DENMARK
View details

Thomas Mejer Hansen

VIP, Associate Professor

Aarhus University

DENMARK
View details

Martin Thomsen

VIP, Associate Professor

Aarhus University

DENMARK
View details

Valentina Medici

Professor

University of California, Davis

UNITED STATES
View details

Mariana Bresque

University of Wisconsin-Madison

UNITED STATES
View details

Johan Bussink

Radboud University Medical Center

NETHERLANDS
View details

Cecilie Bay-Richter

Associate Professor

Aarhus University

DENMARK
View details

Tina Myhre Pedersen

Aarhus University

DENMARK
View details

Ebbe Boedtkjer

VIP, Professor

Aarhus University

DENMARK
View details

Roberta Leonardi

West Virginia University

UNITED STATES
View details

Michelle Møhlenberg

Aarhus University

DENMARK
View details

Kasper Hansen

Tenure Track Assistant Professor

Aarhus University

DENMARK
View details

Elena E. Ferapontova

Assoc. Professor

Aarhus University

DENMARK
View details

Sebastian Nielsen

Aarhus University

DENMARK
View details

Vladimir V. Matchkov

Professor

Aarhus University

DENMARK
View details

Lars Thrane

Aarhus University

DENMARK
View details

Trine Hyrup Mogensen

DVIP-external, Professor

Aarhus University

DENMARK
View details

Søren Degn

VIP, Associate Professor

Aarhus University

DENMARK
View details

Henrik Lauridsen

VIP, Associate Professor

Aarhus University

DENMARK
View details

Michael Pedersen

VIP, Professor

Aarhus University

DENMARK
View details

Niels Henrik Buus

Aarhus University Hospital

DENMARK
View details

Christian Stald Skoven

Aarhus University

DENMARK
View details

Rikke Louise Meyer

Professor

Aarhus University

DENMARK
View details

Lars Poulsen Tolbod

Associate Professor

Aarhus University

DENMARK
View details